Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Hot Flashes 5Breast Neoplasms 4Prostatic Neoplasms 2Head and Neck Neoplasms 2Depression 2Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Sleep Wake Disorders 1Lymphoma, Follicular 1Depressive Disorder, Major 1Depressive Disorder 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Cancer Pain 1Breast Carcinoma In Situ 1Bipolar Disorder 1Adenocarcinoma 1

Interventions

Morphine 16Oxycodone 14Fentanyl 10Methadone 7nabiximols 5Lidocaine 5Acetaminophen 5resiniferatoxin 4Hydromorphone 4Ethanol 4Acupuncture Therapy 4Transcutaneous Electric Nerve Stimulation 3Buprenorphine 3Transcranial Direct Current Stimulation 2Tapentadol 2Surveys and Questionnaires 2Standard of Care 2Sodium Bicarbonate 2Radiosurgery 2Radiofrequency Ablation 2Pharmaceutical Services 2Naloxone 2Ketamine 2Electroacupuncture 2Dronabinol 2Control Groups 2Analgesics, Opioid 26'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2tanezumab 1rofecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cancer Pain × Venlafaxine Hydrochloride × Clear all
NCT04737967 2021-02-04

The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral Neuropathy

Mendel AI

Phase 2/3 Unknown
60 enrolled

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡